Advertisement

Search Results

Advertisement



Your search for Syed Ali Abutalib, MD, and Ruben A. Mesa, MD, FACP,Syed Ali Abutalib, MD, and Ruben A. Mesa, MD, FACP matches 4 pages

Showing 1 - 4


Syed Ali Abutalib, MD, Moves to Advocate Health to Lead Hematology, Transplant Programs

Syed Ali Abutalib, MD, is taking his talents to the recently affiliated Aurora Health Care, now part of Advocate Health, one of the largest integrated health systems in the United States. He accepted a new position at Aurora St. Luke’s Medical Center in Milwaukee, where he is now Director of the...

hematologic malignancies

Novel Targeted Agents for the Treatment of Myelofibrosis

“Progress lies not in enhancing what is, but in advancing toward what will be.”                                                              –Kahlil Gibran To complement The ASCO Post’s continued comprehensive coverage of the 2020 American Society of Hematology (ASH) Annual Meeting &...

hematologic malignancies

Selected ASH Abstracts on Novel Treatments of Polycythemia Vera

To complement The ASCO Post’s continued comprehensive coverage of the 2020 American Society of Hematology (ASH) Annual Meeting & Exposition, here are three abstracts selected from the meeting proceedings focusing on novel therapies for polycythemia vera. For full details of these study...

hematologic malignancies

Study Findings on Myeloproliferative Neoplasms Including Systemic Mastocytosis

HERE IS AN UPDATE on six different studies featured at the 2018 American Society of Hematology (ASH) Annual Meeting & Exposition. Topics focused on novel treatments for myelofibrosis, polycythemia vera and essential thrombocythemia, as well as systemic mastocytosis. Myelofibrosis ABSTRACT...

Advertisement

Advertisement




Advertisement